A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

FDA published a JAMA article on October 15, 2024, describing several areas of focus for regulation of AI used in the medical products. The JAMA article follows a June 2024 FDA blog post by Troy Tazbaz ...

Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...

A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...

Developed by Harvard Medical School, CHIEF was trained on 44 terabytes of data, to make it extremely good at detecting tumors ...

Emory wins $8.3 million grant from the National Institutes for Health that will support a project that aims to develop novel ...

Laos and China have deepened their cooperation in traditional medicine, focusing on medical plant cultivation, research, and ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

A recent study has shown an experimental drug, called RK-33, holds promise in treating breast cancer with bone metastases, ...